- Home
- GENC vs DERM Comparison
GENC vs DERM Comparison
Compare GENC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- DERM
- Stock Information
- Founded
- GENC 1894
- DERM 2014
- Country
- GENC United States
- DERM United States
- Employees
- GENC N/A
- DERM N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- GENC Industrials
- DERM Health Care
- Exchange
- GENC Nasdaq
- DERM Nasdaq
- Market Cap
- GENC 204.9M
- DERM 181.0M
- IPO Year
- GENC N/A
- DERM 2021
- Fundamental
- Price
- GENC $13.79
- DERM $8.06
- Analyst Decision
- GENC
- DERM Strong Buy
- Analyst Count
- GENC 0
- DERM 2
- Target Price
- GENC N/A
- DERM $10.00
- AVG Volume (30 Days)
- GENC 19.9K
- DERM 103.3K
- Earning Date
- GENC 06-13-2025
- DERM 05-14-2025
- Dividend Yield
- GENC N/A
- DERM N/A
- EPS Growth
- GENC 35.02
- DERM N/A
- EPS
- GENC 1.11
- DERM N/A
- Revenue
- GENC $113,116,000.00
- DERM $56,243,000.00
- Revenue This Year
- GENC N/A
- DERM $29.83
- Revenue Next Year
- GENC N/A
- DERM $54.88
- P/E Ratio
- GENC $12.48
- DERM N/A
- Revenue Growth
- GENC 5.44
- DERM N/A
- 52 Week Low
- GENC $10.80
- DERM $3.54
- 52 Week High
- GENC $24.88
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- GENC 56.24
- DERM 65.90
- Support Level
- GENC $13.40
- DERM $6.55
- Resistance Level
- GENC $14.49
- DERM $7.00
- Average True Range (ATR)
- GENC 0.62
- DERM 0.63
- MACD
- GENC 0.02
- DERM 0.13
- Stochastic Oscillator
- GENC 53.02
- DERM 92.41
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.